Showing results (51-60 of 165) with videos related to

Sort By:
Pageof 17
Cancers|December 30, 2020
Inhibitors of the Transcription Factor STAT3 Decrease Growth and Induce Immune Response Genes in Models of Malignant Pleural Mesothelioma (MPM)Moshe Lapidot, Abigail E Case, Dalia Larios, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|May 21, 2009
Molecular dissection of Tomato leaf curl virus resistance in tomato line TY172 derived from Solanum peruvianumIlana Anbinder, Moshe Reuveni, Raviv Azari, et al.
Diseases (Basel, Switzerland)|May 24, 2024
A Single-Center Experience in Combined Oncological-Surgical Treatment for Resectable Locally Advanced Non-Small Cell Lung Cancer (NSCLC)Dan Levy Faber, Abed Agbarya, Ben Caspy, et al.
Planta|December 22, 2014
Targeted mutagenesis using zinc-finger nucleases in perennial fruit treesReut Peer, Gil Rivlin, Sara Golobovitch, et al.
Antioxidants & Redox Signaling|July 3, 2008
Cell cycle regulation by oncogenic tyrosine kinases in myeloid neoplasias: from molecular redox mechanisms to health implicationsMargret S Rodrigues, Mamatha M Reddy, Martin Sattler
Trends in Cancer|February 8, 2023
Precision oncology provides opportunities for targeting KRAS-inhibitor resistanceMartin Sattler, Atish Mohanty, Prakash Kulkarni, et al.
Advances in Experimental Medicine and Biology|August 12, 2003
Mutated tyrosine kinases as therapeutic targets in myeloid leukemiasMartin Sattler, Blanca Scheijen, Ellen Weisberg, et al.
Hematology Reports|November 21, 2023
Chimeric Antigen Receptor T Cell Therapy in Acute Myeloid Leukemia: Trials and TribulationsSwati Garg, Wei Ni, James D Griffin, et al.
Annals of Surgery|December 5, 2020
Pleurectomy Decortication in the Treatment of Malignant Pleural Mesothelioma: Encouraging Results and Novel Prognostic Implications Based on Experience in 355 Consecutive PatientsMoshe Lapidot, Ritu R Gill, Emanuele Mazzola, et al.
Oncotargets and Therapy|January 19, 2018
Spotlight on midostaurin in the treatment of FLT3-mutated acute myeloid leukemia and systemic mastocytosis: design, development, and potential place in therapyEllen Weisberg, Martin Sattler, Paul W Manley, et al.
Pageof 17